REATA PHARMACEUTICALS INC Proceeds from Stock Options Exercised
REATA PHARMACEUTICALS INC reported Proceeds from Stock Options Exercised of $16.89 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-08-08
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2023-06-30 was $3.81M, a 603.70% increase year-over-year.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2023-03-31 was $13.08M, a 6642.78% increase year-over-year.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2022-12-31 was $314.00K, a 83.63% increase year-over-year.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for the quarter ending 2022-09-30 was $436.00K, a 29.38% increase year-over-year.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2022 was $1.49M, a 83.75% decline from fiscal 2021.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2021 was $9.14M, a 48.72% decline from fiscal 2020.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2020 was $17.82M, a 32.54% increase from fiscal 2019.
- REATA PHARMACEUTICALS INC proceeds from stock options exercised for fiscal 2019 was $13.45M, a 613.26% increase from fiscal 2018.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-06-30 | $3.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $16.89M 10-Q · filed 2023-08-08 | $17.20M derived: sum of 3 quarters · filed 2023-08-08 | $17.64M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $13.08M 10-Q · filed 2023-05-10 | $13.39M derived: sum of 2 quarters · filed 2023-05-10 | $13.83M derived: sum of 3 quarters · filed 2023-05-10 | $14.37M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $750.00K derived: sum of 2 quarters · filed 2023-02-24 | $1.29M derived: sum of 3 quarters · filed 2023-08-08 | $1.49M 10-K · filed 2023-02-24 |
| 2022-09-30 | $436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $977.00K derived: sum of 2 quarters · filed 2023-08-08 | $1.17M 10-Q · filed 2022-11-08 | $1.34M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $541.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $735.00K 10-Q · filed 2023-08-08 | $906.00K derived: sum of 3 quarters · filed 2023-08-08 | $1.24M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $194.00K 10-Q · filed 2023-05-10 | $365.00K derived: sum of 2 quarters · filed 2023-05-10 | $702.00K derived: sum of 3 quarters · filed 2023-05-10 | $4.65M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $508.00K derived: sum of 2 quarters · filed 2023-02-24 | $4.46M derived: sum of 3 quarters · filed 2023-02-24 | $9.14M 10-K · filed 2023-02-24 |
| 2021-09-30 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.29M derived: sum of 2 quarters · filed 2022-11-08 | $8.97M 10-Q · filed 2022-11-08 | $16.91M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $8.63M 10-Q · filed 2022-08-08 | $16.57M derived: sum of 3 quarters · filed 2023-02-24 | $24.66M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $4.68M 10-Q · filed 2022-05-10 | $12.62M derived: sum of 2 quarters · filed 2023-02-24 | $20.71M derived: sum of 3 quarters · filed 2023-02-24 | $21.08M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $16.03M derived: sum of 2 quarters · filed 2023-02-24 | $16.40M derived: sum of 3 quarters · filed 2023-02-24 | $17.82M 10-K · filed 2023-02-24 |
| 2020-09-30 | $8.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $8.46M derived: sum of 2 quarters · filed 2021-11-08 | $9.88M 10-Q · filed 2021-11-08 | $16.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $364.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.79M 10-Q · filed 2021-08-09 | $8.78M derived: sum of 3 quarters · filed 2022-02-28 | $9.15M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.42M 10-Q · filed 2021-05-06 | $8.42M derived: sum of 2 quarters · filed 2022-02-28 | $8.78M derived: sum of 3 quarters · filed 2022-02-28 | $9.82M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $7.36M derived: sum of 2 quarters · filed 2022-02-28 | $8.39M derived: sum of 3 quarters · filed 2022-02-28 | $13.45M 10-K · filed 2022-02-28 |
| 2019-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.40M derived: sum of 2 quarters · filed 2020-11-09 | $6.45M 10-Q · filed 2020-11-09 | $6.83M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $6.08M 10-Q · filed 2020-08-10 | $6.47M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $5.05M 10-Q · filed 2020-05-11 | $5.43M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.89M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $1.50M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $660.00K 10-K · filed 2020-02-19 |